SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-163800
Filing Date
2022-05-31
Accepted
2022-05-31 15:01:00
Documents
12
Period of Report
2022-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d356349d8k.htm   iXBRL 8-K 37505
  Complete submission text file 0001193125-22-163800.txt   156364

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20220524.xsd EX-101.SCH 2861
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20220524_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20220524_pre.xml EX-101.PRE 10816
6 EXTRACTED XBRL INSTANCE DOCUMENT d356349d8k_htm.xml XML 3272
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 22982727
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences